Mindfulness: A Kindly Approach to Being with Cancer offers people with cancer a means to bring mindfulness and kindliness into their lives, to help them cope with the challenge of a life-threatening illness. * Adapts Mindfulness-Based Cognitive Therapy (MBCT), an approach with a strong evidence base for people with recurrent depression, for the needs and challenges of people with cancer * Presents the standard 8-week course of MBCT for cancer in a flexible format that is designed to suit each reader s own particular timescale, context and situation * Based on more than 15 years of program development and clinical application by the author, and the work and experience of mindfulness teachers in other cancer centres around the world * Provides specific practices and approaches tailored to support the different phases of a cancer experience from diagnosis and treatment to living with uncertainty and managing life with cancer * Features five extended stories from people personally affected by cancer who have used mindfulness-based practices to support them in their own experience of illness, life and treatment

In this first authoritative overview on modern cancer chemotherapy 121 international specialists have contributed their experience and recent data for what is likely to become the gold standard in the field. The authors summarize knowledge gained over the past decade, from basic concepts to successful applications in the clinic, covering active and passive targeting strategies as well as tissue-specific approaches. All current and future targeted delivery systems are discussed, from ligand-based to antibody-based polymer-based systems, right up to micro- and nanoparticulate systems. A special section covers the delivery of nucleic acid therapeutics, such as siRNA, miRNA and antisense nucleotides. In each case, a description of the basic technique is followed by a discussion of the latest preclinical and clinical developments in the field. By virtue of its clear and didactic structure, rich illustrative material and summary chapters, this handbook and ready reference enables the efficient transfer of knowledge between different disciplines, from basic research to the clinician and vice versa. It is equally well suited for professionals, researchers and students in medical oncology and cancer biology, and is also excellent for teaching medical students the foundations of 21st century cancer chemotherapy. Click here to listen to Dr Kratz's Expert Commentary as he discusses where the field of drug delivery in oncology has made advances in the last ten years, and which therapeutic approaches may have promise for the next generations of anti-tumor agents, including nucleic acid and antibody-based approaches.

This is the fifth edition of a very successful textbook on clinical trials methodology, written by recognized leaders who have long and extensive experience in all areas of clinical trials. The three authors of the first four editions have been joined by two others who add great expertise. A chapter on regulatory issues has been included and the chapter on data monitoring has been split into two and expanded. Many contemporary clinical trial examples have been added. There is much new material on adverse events, adherence, issues in analysis, electronic data, data sharing and international trials. This book is intended for the clinical researcher who is interested in designing a clinical trial and developing a protocol. It is also of value to researchers and practitioners who must critically evaluate the literature of published clinical trials and assess the merits of each trial and the implications for the care and treatment of patients. The authors use numerous examples of published clinical trials to illustrate the fundamentals. The text is organized sequentially from defining the question to trial closeout. One chapter is devoted to each of the critical areas to aid the clinical trial researcher. These areas include pre-specifying the scientific questions to be tested and appropriate outcome measures, determining the organizational structure, estimating an adequate sample size, specifying the randomization procedure, implementing the intervention and visit schedules for participant evaluation, establishing an interim data and safety monitoring plan, detailing the final analysis plan and reporting the trial results according to the pre-specified objectives. Although a basic introductory statistics course is helpful in maximizing the benefit of this book, a researcher or practitioner with limited statistical background would still find most if not all the chapters understandable and helpful. While the technical material has been kept to a minimum, the statistician may still find the principles and fundamentals presented in this text useful.

This book provides an overview of the latest advances in head and neck cancer using a multidisciplinary approach. Commencing with a discussion of epidemiological and diagnostic aspects, including the role of vaccination and key pathological features, the book then follows by examining the role of oncogenomics, proteomics, next generation sequencing and homologous recombination function in predicting outcomes. The topics are presented by epidemiologists, pathologists and basic scientists with further contributions from medical oncologists, head and neck cancer surgical specialists (ORL /HNS), and radiation oncologists in chapters that discuss therapeutic approaches for oral, oropharyngeal and thyroid cancer. Special topics such as the development of novel staging classifications, optimal larynx preservation approaches for laryngeal and hypopharyngeal cancer, surgical reconstruction, new surgical approaches in oropharynx cancer, potential for treatment de-escalation, systemic therapy in nasopharyngeal cancer and salivary gland tumors and treatment approaches for tumors of unknown primary site are discussed in detail. Finally, the role of immunotherapy in the field is highlighted. The chapters are based on the latest data presented at the 6th Trends in Head and Neck Oncology Conference and reflect the most up-to-date information in the field. They are written by many of the most internationally acclaimed authors in the field and are therefore an excellent source for all those interested or actively working in the field of head and neck cancer.

This book comprehensively summarizes the adverse effects of tobacco smoking on human health. The current second edition has integrated a large set of new data that have been published in numerous scientifc studies and meta-analyses over the past few years. Unfortunately, the harmful sequelae of tobacco smoking are played down by the ind- try and politicians in many industrialized countries. However, about 800,000 people/year in the EU die from the immediate consequences of smoking. The particularly insidious feature of tobacco consumption is that smoking-attributable harmful effects on health do not generally become apparent until three or four decades after smoking initiation. Although some positive changes in the legislative handling of tobacco have appeared in the past fve years, we still need to form a pact, sealed by politicians, the medical prof- sionals, teachers and the media, to target the problem across nations. In this respect, a minority of countries, including the US and the UK, have given positive examples. There are four areas that need to be improved in future: (1) strict bans on tobacco adv- tisement on a global level, (2) better measures to protect against side-stream (passive) smoke exposure, (3) establishment of prevention programs, especially for children and (4) tre- ment of tobacco addiction.

This book focuses on the pathological diagnosis of primary hepatic and bile duct tumors, and introduces the "Three Types and Six Sub-types" classification of hepatobiliary tumors. With more than 600 figures, including photographs and microscopy images, it highlights morphology, immunology and molecular pathology and their correlations with hepatic surgery and hepatic oncology. The book reviews the pathobiological characteristics of hepatic tumors and reveals the latest developments in this field. It is a valuable reference resource for hepatologists, pathologists and researchers.

This book aims to bring together a broad variety of examples of the role of pharmacogenomics in current drug development, uncovering dynamic concentration-dependent drug responses on biological systems to understand pharmacodynamics responses in human cancer where genetic lesions serve as tumor markers and provide a basis for cancer diagnosis. The book describes methods and protocols applied in molecular diagnostics. It offers pathologists and researchers providing molecular diagnostic services an array of the most recent and readily accessible reference to compare methods and techniques. Highlights include the molecular diagnosis of genetic aberrations by quantitative polymerase reaction (qPCR), sequence-specific oligonucleotide arrays, next-generation sequencing (NGS), CGH arrays-and methodologies directed at the detection of epigenetic events, high-throughput nucleic acid and protein arrays, direct sequencing and FISH-based methodologies, currently used in the diagnosis of solid tumors. The book also includes an innovative line of treatment in relation to the molecular prognosis, diagnosis and pharmacogenomics in the actual practice of clinical findings at molecular levels. The book covers the applications of numerous genetic testing methodologies; in approximately the chronological order of discovery and high-throughput diagnosis using advanced genomic approaches to identify such genes, in the search for novel drug targets and/or key determinants of drug reactions. It also promotes a wider understanding of molecular diagnostics among physicians, medical students, and scientists in academics, industry and corporate world.

Experts from around the world review the current field of the immunobiology of heat shock proteins, and provide a comprehensive account of how these molecules are spearheading efforts in the understanding of various pathways of the immune system. This one-stop resource contains numerous images to both help illustrate the research on heat shock proteins, and better clarify the field for the non-expert. Heat shock proteins (HSPs) were discovered in 1962 and were quickly recognized for their role in protecting cells from stress. Twenty years later, the immunogenicity of a select few HSPs was described, and for the past 30 years, these findings have been applied to numerous branches of immunology, including tumor immunology and immunosurveillance, immunotherapy, etiology of autoimmunity, immunotherapy of infectious diseases, and expression of innate receptors. While HSPs can be used to manipulate immune responses by exogenous administration, they appear to be involved in initiation of de novo immune responses to cancer and likely in the maintenance of immune homeostasis.

This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy. Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches. Supportive care and management of the condition in resource poor countries are also discussed in detail. This is an indispensable guide for research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood leukemia.

Surgical Techniques for Kidney Cancer provides a comprehensive review and detailed description of surgical techniques for kidney and adrenal cancer. Through a step by step approach various surgical techniques are covered including radical nephrectomy, partial nephrectomy, and thermal ablation for renal cortical tumors. Each step by step approach is followed by the latest data on outcomes. Furthermore, limitations as well as tips and tricks are detailed in addition to management of common complications. Kidney Surgery for Urologists will be a valuable resource for Urologists, Urological Surgeons, Fellows in Urologic Oncology and Minimally Invasive/Robotic Surgery as well as upper level residents training in Urology.

This volume focuses on the relationship between the regulation of signal transduction and disease mechanisms, and discusses how the dysregulation of intracellular signals cause diseases, cell death, carcinogenesis, and other disorders. Growth, survival, transformation, and metabolic activities at the cellular level are regulated by various intracellular signal transduction pathways. Sources that stimulate intracellular signals include intracellular stresses and signal regulators/modulators, as well as extracellular growth factors. Recent studies on signal transduction analysis using animal and human cell lines have revealed how the intracellular signals are regulated and why their dysregulation leads to pathological states such as tumorigenesis, metabolic diseases, cell death, and so on. This book highlights several important key molecules and intracellular signaling pathways such as microRNA, the TGF-beta signaling pathway, the Wnt signaling pathway and MET signaling pathway as topical and highly relevant issues in human cell research related to signal transduction. In addition to assessing the pathogenic role of these signaling pathways, it focuses on the molecular design of small molecule regulators/inhibitors of said pathways, one of the most important approaches in this area. This book offers a valuable guide, helping not only research scientists but also clinicians to understand how the dysregulation of intracellular signals leads to diseases.

This vital collection provides a unique set of techniques to explore the clinical, pathological, and research aspects of the management of patients with esophageal adenocarcinoma. Beginning with an introduction to the basic features of esophageal adenocarcinoma, the book continues with clinical protocols for the management of the cancer, pathological methods for management of the patients and research, as well as protocols for molecular research, which could aid researchers in furthering our understanding of pathogenesis as well as in identifying new targets for the treatment and prevention of adenocarcinoma. Written for the highly successful Methods in Molecular Biology series, chapters include introductions on their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls. Comprehensive and authoritative, Esophageal Adenocarcinoma: Methods and Protocols is a valuable guide to stimulate specialists from various disciplines in their continuing research into esophageal adenocarcinoma and translating that research into improving the management of this cancer of rising importance.

Surgical neuropathology is a challenging arena for many pathologists, due in large part to a relative lack of experience of most pathologists in this area compared to other areas of surgical pathology. "Brain Tumors" is intended to address this need with cases drawn from the surgical neuropathology practices of the authors.

This volume provides examples of over 100 brain tumors, running the gamut from the very common to the rare. Each example is presented in a case based format and the wide variety of cases presented covers the entire scope of brain tumors and offers the opportunity to review both the basics for the beginner or relatively inexperienced pathologist and also offers experienced pathologists the chance to see some of the rare entities.

Each case is formatted as if it were a consult case and includes a brief clinical history, description of the pathologic findings with numerous illustrations, the line diagnosis, discussion of the entity, and the diagnostic thought process as well pertinent references for further reading. When relevant, current practical applications of immunohistochemistry and molecular pathology are discussed. The Consultant Pathology Series

"The Consultant Pathology series" is designed to disseminate the knowledge of expert surgical pathology consultants in the analysis and diagnosis of difficult cases to the full community of pathology practitioners. The volumes are based on actual consultations and presented in a format that illustrates the expert's process of evaluating the case, including indications for consultation, the consultants findings and comment, and discussion of the entity that amplifies the case description. Each volume in the "Consultant Pathology series" is authored by international experts with extensive case experience in the areas covered

Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of cancer diagnosis and treatment taking a balanced, authoritative and, -where possible- evidence-based stance. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a comprehensive understanding of the field of oncology, with an emphasis on prevention and early detection.

This book provides a comprehensive overview of ZIC-family research. Part1 summarizes the ZIC family in animal evolution and development and presents an overall picture of the ZIC family gene structure in eumetazoan animals, providing an evolutionary hypothesis and reviewing the studies on the role of ZIC family proteins in developmental processes for each animal model. Part 2 shows that the ZIC family are the causative genes for developmental disorders, and discusses the role of the ZIC family in stem cell biology. It also presents studies on the ZIC family in the medical biology field. This interdisciplinary book is a valuable resource not only for those people directly involved in ZIC-family-related research, but also researchers in diverse research fields who are interested in the latest advances in biology and medicine.

This thesis presents the development of theranostic gold nanostars (GNS) for multimodality cancer imaging and therapy. Furthermore, it demonstrates that a novel two-pronged treatment, combining immune-checkpoint inhibition and GNS-mediated photothermal nanotherapy, can not only eradicate primary treated tumors but also trigger immune responses to treat distant untreated tumors in a mouse animal model. Cancer has become a significant threat to human health with more than eight million deaths each year, and novel methods for cancer management to improve patients' overall survival are urgently needed. The developed multifunctional GNS nanoprobe with tip-enhanced plasmonics in the near-infrared region can be combined with (1) surface-enhanced Raman spectroscopy (SERS), (2) two-photon photoluminescence (TPL), (3) X-ray computed tomography (CT), (4) magnetic resonance imaging (MRI), (5) positron emission tomography (PET), and (6) photothermal therapy (PTT) for cancer imaging and treatment. The ability of the GNS nanoprobe to detect submillimeter intracranial brain tumors was demonstrated using PET scan - a superior non-invasive imaging modality - in a mouse animal model. In addition, delayed rechallenge with repeated cancer cell injection in cured mice did not lead to new tumor formation, indicating generation of a memorized immune response to cancer. The biocompatible gold nanostars with superior capabilities for cancer imaging and treatment have great potential for translational medicine applications.

"The Royal Marsden Hospital Handbook of Wound Management in Cancer Care" offers evidence-based guidance on wound management in a practical and easily accessible format. An introduction to wound healing and assessment is followed by the management of specific wound types and a detailed chapter on wound management products. This book is unique in bringing together invaluable specialist advice, expert opinion and research on the management of wounds related to cancer and cancer therapies. It will be an essential reference for nurses and health care professionals working in the fields of oncology and palliative care, in both community and hospital settings.The key features include: a quick and easy reference for the management of simple, complex and/or chronic wounds; highly referenced throughout with numerous colour pictures; evidence-based outlines for the management of wounds in cancer care; and continues the tradition of best practice and high quality patient care set by the bestselling text "The Royal Marsden Hospital Manual of Clinical Nursing Procedures". The Royal Marsden Hospital is the largest comprehensive cancer centre in Europe and is one of the world's foremost hospitals dedicated to the care of people with cancer.

Published in association with the European Society of Medical Oncology, this book is designed for trainee oncologists, oncology nurses, and those working with cancer patients on a day-to-day basis. Using an accessible writing style suitable for a wide audience of caregivers, the book focuses on the "soft skills" required in communicating with patients. Topics include the aetiology of cancer, diagnosis and staging, and explaining the purpose of treatment, including chemotherapy, hormone treatment, and immunological and gene-based therapies. The book also discusses patient support groups, monitoring remission, and relapse. Communicating with Cancer Patients is written by UK oncologists but has wide international application.

Handbook of Hematologic Malignanciesprovides a unique, practical, and concise guide focused on the must-know points of diagnosis, prognosis, therapeutic management, and cutting edge clinicaltrial opportunities for each hematologic malignancy. With an ever-increasing growth of evidence and a significant expansion of available treatment optionsfor patients with hematologic disease, remaining current and up to date can be extremely challenging for practicing clinicians. This comprehensivesubspecialty handbook is designed and organized for the busy hematologist, hematologic oncologist, hematopathologist, and trainee in mind. Every chapter is richly illustrated with color figures and flow diagrams, and contains helpful tables on differential diagnosis, prognostic scoring systemsand therapeutic options. A concise case-based review for testing pathologic diagnosis and clinical knowledge for each chapter is included near the end ofthe book as well as provided in an online compendium. Written by experienced clinicians at the world-renowned Moffitt Cancer Center in Tampa, Florida, aswell as contributions from leading academicians throughout the country, this handbook is an essential resource for anyone diagnosing, treating, or managingpatients with hematologic malignancy. Key Features:Contains clear prognostic and diagnostic tools (e.g. tables/flow diagrams/pathology images) with emphasis on key differential diagnoses and diagnostic dilemmasEasy to use treatment recommendations with bullet point format and key references.Discusses the future of patient management based on practice changing clinical trialsOnline compendium of clinical scenarios/questions with high resolution pathology images linked to each individual chapter

Gastroesophageal cancers are the most common form of cancer incidents, and the second most common cause of death among cancer patients. In 2000, it was estimated that over one million new cases of gastroesophageal cancers were diagnosed worldwide, and over 900,000 individuals died from the disease.

Using a multi-disciplinary approach, "Esophageal Cancer: Principles and Practice" addresses the complexities encountered in the understanding and management of esophageal cancers. Written by the worldis leading experts in surgery, medical oncology, radiation oncology, gastroenterology, pathology, radiology, nutrition, nurse specialists, palliative medicine, and research relating to neoplasia of the esophagus, this text will serve as the definitive resource and enable practitioners to provide the best possible patient care. Presented in an accessible and useful format, this text is a valuable reference to all practitioners participating in the care of this high-needs population.

Special Features Include: Complete coverage of the two most common tumors: squamous cell carcinoma and adenocarcinoma In-depth coverage of uncommon tumors In-depth coverage of each topic with equal emphasis applied to both technical and multidisciplinary aspects of treatment In-depth treatment of non-surgical topics in management at different phases of the disease Wide-ranging attention to the diseaseis biologic aspects and basic science, contributing greatly to palliative care

This volume provides the most updated knowledge on the advancement of molecular pathogenesis, molecular diagnosis, and therapy development for hepatocellular carcinoma (HCC). Topics covered include the etiology and pathogenesis of HCC, recent advances in HCC genomics, biomarker discovery and validation in HCC diagnosis, the role of liver biopsy in HCC early diagnosis, and the future prospects of surgical approaches and targeted therapy for HCC. In addition to reviewing the current available knowledge, the book also discusses the future development of a precision and personalized medicine approach for HCC. Written by experts in the field, Precision Molecular Pathology of Liver Cancer is a concise yet comprehensive resource for practitioners who treat patients with hepatocellular carcinoma.

The field of oncology benefits from several large-scale reference books and a host of monographs dedicated to specific cancers. However, truly excellent practice and review books are, surprisingly, quite scarce. Outside of a scant handful of books and online reference tools that offer clinical response practice and board review in a basic question and answer format, there are no resources that offer a robust, engaging, fully referenced tool for these vital activities in every oncologist's and oncology trainee's work. This print and electronic book seeks to fill that void, offering comprehensive question-and-answer style content that covers the entire specialty of oncology and provides practicing oncologists with a fascinating and immediately applicable compendium of vital information dealing with a well-balanced selection of common and uncommon cancers. At the heart of this book is the editor's and authors' desire to overcome the controversies and barriers to practice that usually emerge following the appearance of new data. In every section, the user is guided toward collaboration in ongoing clinical research - for example, via discussions of well-designed ongoing clinical trials in each specific area.

Developed with both the teacher and learner in mind, this book also offers trainees and fellows an excellent opportunity to enhance their preparation for the ABIM oncology fellowship exam as well as for the oncology boards. It will also be an extremely useful tool for oncologists working toward the recertification exam. This comprehensive, beefy book includes hundreds of painstakingly developed multiple-choice and mini-case-based questions covering the principles of medical oncology, malignant hematology, surgical oncology, and radiation oncology. It also contains mini-cases and questions dealing with the biology, diagnosis, classification, staging, and multidisciplinary treatment of cancers at every anatomic site. The very latest topics are included, such as molecular techniques, targeted therapies, and translational cancer research. Concise but detailed answers are referenced to key journals and books, and evidence-based wherever possible. NCCN guidelines are also referenced as appropriate. With its powerful focus on take-home messages from and for actual clinical work, this book will help keep oncologists up to date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base.

This book provides a comprehensive, state-of-the-art review of the diagnosis and management of retroperitoneal tumors. It highlights current surgical techniques for combined resection and reconstruction of various abdominal and pelvic organs and structures, along with adjuvant therapy. The book consists of three parts: Part 1 summarizes basic knowledge on retroperitoneal tumors and provides a detailed introduction to diagnosis and treatment, while Part 2 focuses on the surgical techniques used for retroperitoneal tumors and describes general procedures for operations on retroperitoneal tumors at different sites. Lastly, Part 3 details the etiology, pathology, evaluation, treatment and prognosis of retroperitoneal tumors according to pathological subtypes. This book is designed as a resource and guide for surgical and medical oncologists working with retroperitoneal tumors.

Mistletoe is a parasitic evergreen plant that lives on trees such apple and elm. Modern complementary therapies for cancer increasingly make use of mistletoe preparations. However, because mistletoe grows on many different trees, the properties of the plant vary according to the host tree. For the first time, this book presents an important reference for practitioners on the characteristics of each type of mistletoe, and what kind of cancers they are best suited to treat. Thirteen host trees are described, covering all aspects from mythology and botany to homeopathy and flower essences. The author then pulls the various characteristics together to provide a unique guide to which patients might benefit most from the different types of mistletoe. The results will be useful not only in treating cancer but also in prevention. The book includes specific case-studies as well as notes on supplementary therapies using metals.

When Julie Wiltshire's husband, David, was diagnosed with cancer twice, he faced a series of treatments made all the more difficult by multiple complications. In A Carer's Chaos, Julie records the details of David's long journey of cancer treatment, but also offers a unique perspective into life as a carer to a loved one, exploring the love, hate, anger, loneliness and fear experienced on a daily basis by a carer. The book explores how a person's life can be turned upside down when their partner's life is threatened, and how the chaos a carer experiences can be frightening and exhausting as they attempt to swim through a sea of complications. Written with the intention of highlighting the carer's experience, Julie offers readers the chance to glimpse into the emotions experienced by a carer as they try to maintain their own individuality whilst caring for a loved one. She demonstrates through her own experience how often a carer is overlooked and experiences isolation as much of the attention and care is focused on the ill patient. Inspired and informed by Julie's recent experiences, A Carer's Chaos is a unique memoir that will appeal to readers facing a similar situation.